Latest Pharmaceutical Industry News

Page 4 of 4

Dimerix Secures $107M Japan Deal as ACTION3 Trial Hits Key Milestone

Dimerix Limited has inked a lucrative licensing agreement with Fuso Pharmaceutical for its kidney disease drug DMX-200 in Japan, while completing recruitment for its pivotal Phase 3 ACTION3 trial.

Victor Sage

28 Jan 2025

Top